Savvy Updates 6/17/24: Abbott Lingo & Libre Rio, Oral Insulin, Sensulin Smart Insulin, Biomea Fusion on Clinical Hold, Hydration Hacks, CGM Insurance Coverage, Diabetes Products Putting Profits Over Patients

Savvy Updates 6/17/24: Abbott Lingo & Libre Rio, Oral Insulin, Sensulin Smart Insulin, Biomea Fusion on Clinical Hold, Hydration Hacks, CGM Insurance Coverage, Diabetes Products Putting Profits Over Patients

Jun 17, 2024 | Diabetes Business, Featured, Podcasts, Research News, Technology Updates

FDA approves Abbott’s Lingo and Libre Rio glucose monitoring systems by Archana Rani for MedicalDevice-Network.com, June 2024. The US Food and Drug Administration (FDA) has approved Abbott’s Lingo and Libre Rio over-the-counter continuous glucose monitoring (CGM)...
Savvy Updates 9/5/23: InsuletGets TRO Against EOFlow, Beta Bionics Raises $100M, Research Grant for Liver Targeted Insulin, History/Future or DIY “Bionic Pancreas”, 1st Ten Drugs for Medicare Price Negoation, WellDoc’s Blue Star Gets FDA Clearance, Men & Women Differ in Cardiac Arrest Symptoms, CGM Companies Go Mainstream

Savvy Updates 9/5/23: InsuletGets TRO Against EOFlow, Beta Bionics Raises $100M, Research Grant for Liver Targeted Insulin, History/Future or DIY “Bionic Pancreas”, 1st Ten Drugs for Medicare Price Negoation, WellDoc’s Blue Star Gets FDA Clearance, Men & Women Differ in Cardiac Arrest Symptoms, CGM Companies Go Mainstream

Sep 5, 2023 | Diabetes Business, Featured, LOOPing, Research News, Technology Updates

Insulet gains amid winning TRO in dispute with EOFlow, CEO insider buy by Joshua Fineman for SeekingAlpha.com, 30 August 2023.   Insulet rose 8.1% at least partly after the insulin pump maker was granted a temporary restraining order in a trade secrets case...
Savvy Updates, 6/6/22: Abbott Libre 3 & Lingo, Diabeloop $$, iLet Bionic Pancreas Trial, Apple Watch BG Monitoring, Medtronic Struggles, Diabetes & Long Covid, Dexcom Denies Rumors, Pharmacy Benefit Managers Cost Consumers

Savvy Updates, 6/6/22: Abbott Libre 3 & Lingo, Diabeloop $$, iLet Bionic Pancreas Trial, Apple Watch BG Monitoring, Medtronic Struggles, Diabetes & Long Covid, Dexcom Denies Rumors, Pharmacy Benefit Managers Cost Consumers

Jun 6, 2022 | Featured, Research News, Technology Updates

ABBOTT NEWS US FDA approves Abbott’s FreeStyle Libre 3 system for diabetic patients was reported by MedicalDevice-Network.com, 1 June 2022.   The US Food and Drug Administration (FDA) has granted clearance to Abbott’s next-generation FreeStyle...
Skip to content